The effect of tumor burden on ornithine decarboxylase activity in mice

Rami Saydjari, Robert W. Alexander, James R. Upp, Graeme J. Poston, Sam C. Barranco, Courtney Townsend, James C. Thompson

Research output: Contribution to journalArticle

2 Citations (Scopus)

Abstract

Polyamines are essential for cell growth of normal and neoplastic tissue. αDifluoromethylornithine (DFMO) is a known irreversible inhibitor or ornithine decarboxylase (ODC), the rate-limiting enzyme in polyamine biosynthesis. The purpose of this study was to examine the effects of tumor burden on ODC in tissues of tumorbearing compared with tumor-free mice. Twenty-eight male Balb/c mice were divided into four groups of 7 each. Groups 1 and 2 were inoculated subcutaneously with 10 X 106 MC-26 mouse colon adenocarcinoma cells. Groups 3 and 4 were kept as tumor-free controls. Ten days after inoculation, groups 2 and 4 were injected with DFMO (200 mg/kg) intraperitoneally (IP) while Groups 1 and 3 received saline. Two hours after the injection of DFMO the animals were sacrificed. The tumor, pancreas, kidney, and liver were excised and analyzed for ODC activity. DFMO caused a significant reduction (compared with controls that did not receive DFMO) in the ODC activity of tumors; however, ODC activity of the kidney, pancreas, and liver of tumor-bearing mice was not affected. Additionally, the basal ODC activity in the kidney, liver, and pancreas of tumor-bearing mice was significantly lower compared with tumor-free controls. DFMO lowered ODC activity in the kidney, pancreas, and liver of tumor-free mice. These results suggest that the presence of MC-26 tumor causes systemic effects that alter ODC activity and the response to a known inhibitor of ODC.

Original languageEnglish (US)
Pages (from-to)415-419
Number of pages5
JournalCancer Investigation
Volume9
Issue number4
DOIs
StatePublished - 1991

Fingerprint

Ornithine Decarboxylase
Tumor Burden
Eflornithine
Neoplasms
Pancreas
Kidney
Liver
Polyamines
Colon
Adenocarcinoma
Injections

ASJC Scopus subject areas

  • Cancer Research
  • Oncology

Cite this

Saydjari, R., Alexander, R. W., Upp, J. R., Poston, G. J., Barranco, S. C., Townsend, C., & Thompson, J. C. (1991). The effect of tumor burden on ornithine decarboxylase activity in mice. Cancer Investigation, 9(4), 415-419. https://doi.org/10.3109/07357909109084639

The effect of tumor burden on ornithine decarboxylase activity in mice. / Saydjari, Rami; Alexander, Robert W.; Upp, James R.; Poston, Graeme J.; Barranco, Sam C.; Townsend, Courtney; Thompson, James C.

In: Cancer Investigation, Vol. 9, No. 4, 1991, p. 415-419.

Research output: Contribution to journalArticle

Saydjari, R, Alexander, RW, Upp, JR, Poston, GJ, Barranco, SC, Townsend, C & Thompson, JC 1991, 'The effect of tumor burden on ornithine decarboxylase activity in mice', Cancer Investigation, vol. 9, no. 4, pp. 415-419. https://doi.org/10.3109/07357909109084639
Saydjari, Rami ; Alexander, Robert W. ; Upp, James R. ; Poston, Graeme J. ; Barranco, Sam C. ; Townsend, Courtney ; Thompson, James C. / The effect of tumor burden on ornithine decarboxylase activity in mice. In: Cancer Investigation. 1991 ; Vol. 9, No. 4. pp. 415-419.
@article{c07e082dfdaf4c22a74ae3025cbb3599,
title = "The effect of tumor burden on ornithine decarboxylase activity in mice",
abstract = "Polyamines are essential for cell growth of normal and neoplastic tissue. αDifluoromethylornithine (DFMO) is a known irreversible inhibitor or ornithine decarboxylase (ODC), the rate-limiting enzyme in polyamine biosynthesis. The purpose of this study was to examine the effects of tumor burden on ODC in tissues of tumorbearing compared with tumor-free mice. Twenty-eight male Balb/c mice were divided into four groups of 7 each. Groups 1 and 2 were inoculated subcutaneously with 10 X 106 MC-26 mouse colon adenocarcinoma cells. Groups 3 and 4 were kept as tumor-free controls. Ten days after inoculation, groups 2 and 4 were injected with DFMO (200 mg/kg) intraperitoneally (IP) while Groups 1 and 3 received saline. Two hours after the injection of DFMO the animals were sacrificed. The tumor, pancreas, kidney, and liver were excised and analyzed for ODC activity. DFMO caused a significant reduction (compared with controls that did not receive DFMO) in the ODC activity of tumors; however, ODC activity of the kidney, pancreas, and liver of tumor-bearing mice was not affected. Additionally, the basal ODC activity in the kidney, liver, and pancreas of tumor-bearing mice was significantly lower compared with tumor-free controls. DFMO lowered ODC activity in the kidney, pancreas, and liver of tumor-free mice. These results suggest that the presence of MC-26 tumor causes systemic effects that alter ODC activity and the response to a known inhibitor of ODC.",
author = "Rami Saydjari and Alexander, {Robert W.} and Upp, {James R.} and Poston, {Graeme J.} and Barranco, {Sam C.} and Courtney Townsend and Thompson, {James C.}",
year = "1991",
doi = "10.3109/07357909109084639",
language = "English (US)",
volume = "9",
pages = "415--419",
journal = "Cancer Investigation",
issn = "0735-7907",
publisher = "Informa Healthcare",
number = "4",

}

TY - JOUR

T1 - The effect of tumor burden on ornithine decarboxylase activity in mice

AU - Saydjari, Rami

AU - Alexander, Robert W.

AU - Upp, James R.

AU - Poston, Graeme J.

AU - Barranco, Sam C.

AU - Townsend, Courtney

AU - Thompson, James C.

PY - 1991

Y1 - 1991

N2 - Polyamines are essential for cell growth of normal and neoplastic tissue. αDifluoromethylornithine (DFMO) is a known irreversible inhibitor or ornithine decarboxylase (ODC), the rate-limiting enzyme in polyamine biosynthesis. The purpose of this study was to examine the effects of tumor burden on ODC in tissues of tumorbearing compared with tumor-free mice. Twenty-eight male Balb/c mice were divided into four groups of 7 each. Groups 1 and 2 were inoculated subcutaneously with 10 X 106 MC-26 mouse colon adenocarcinoma cells. Groups 3 and 4 were kept as tumor-free controls. Ten days after inoculation, groups 2 and 4 were injected with DFMO (200 mg/kg) intraperitoneally (IP) while Groups 1 and 3 received saline. Two hours after the injection of DFMO the animals were sacrificed. The tumor, pancreas, kidney, and liver were excised and analyzed for ODC activity. DFMO caused a significant reduction (compared with controls that did not receive DFMO) in the ODC activity of tumors; however, ODC activity of the kidney, pancreas, and liver of tumor-bearing mice was not affected. Additionally, the basal ODC activity in the kidney, liver, and pancreas of tumor-bearing mice was significantly lower compared with tumor-free controls. DFMO lowered ODC activity in the kidney, pancreas, and liver of tumor-free mice. These results suggest that the presence of MC-26 tumor causes systemic effects that alter ODC activity and the response to a known inhibitor of ODC.

AB - Polyamines are essential for cell growth of normal and neoplastic tissue. αDifluoromethylornithine (DFMO) is a known irreversible inhibitor or ornithine decarboxylase (ODC), the rate-limiting enzyme in polyamine biosynthesis. The purpose of this study was to examine the effects of tumor burden on ODC in tissues of tumorbearing compared with tumor-free mice. Twenty-eight male Balb/c mice were divided into four groups of 7 each. Groups 1 and 2 were inoculated subcutaneously with 10 X 106 MC-26 mouse colon adenocarcinoma cells. Groups 3 and 4 were kept as tumor-free controls. Ten days after inoculation, groups 2 and 4 were injected with DFMO (200 mg/kg) intraperitoneally (IP) while Groups 1 and 3 received saline. Two hours after the injection of DFMO the animals were sacrificed. The tumor, pancreas, kidney, and liver were excised and analyzed for ODC activity. DFMO caused a significant reduction (compared with controls that did not receive DFMO) in the ODC activity of tumors; however, ODC activity of the kidney, pancreas, and liver of tumor-bearing mice was not affected. Additionally, the basal ODC activity in the kidney, liver, and pancreas of tumor-bearing mice was significantly lower compared with tumor-free controls. DFMO lowered ODC activity in the kidney, pancreas, and liver of tumor-free mice. These results suggest that the presence of MC-26 tumor causes systemic effects that alter ODC activity and the response to a known inhibitor of ODC.

UR - http://www.scopus.com/inward/record.url?scp=0025816364&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0025816364&partnerID=8YFLogxK

U2 - 10.3109/07357909109084639

DO - 10.3109/07357909109084639

M3 - Article

VL - 9

SP - 415

EP - 419

JO - Cancer Investigation

JF - Cancer Investigation

SN - 0735-7907

IS - 4

ER -